Inactive Instrument

News Jounce Therapeutics, Inc.

Equities

JNCE

US4811161011

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

Graphite Bio, Inc. Announces Executive Changes	23-08-23	CI
JOUNCE THERAPEUTICS, INC. : Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year (form 8-K)	23-05-04	AQ
Jounce Therapeutics, Inc. Announces Board Changes	23-05-04	CI
Jounce Therapeutics, Inc.(NasdaqGS:JNCE) dropped from NASDAQ Composite Index	23-05-04	CI
Jounce Therapeutics, Inc.(NasdaqGS:JNCE) dropped from S&P Global BMI Index	23-05-04	CI
Jounce Therapeutics, Inc.(NasdaqGS:JNCE) dropped from S&P TMI Index	23-05-04	CI
Jounce Therapeutics Announces Closing of Tender Offer	23-05-03	AQ
Concentra Biosciences, LLC completed the acquisition of Jounce Therapeutics, Inc. from Tang Capital Management, LLC and others.	23-05-02	CI
Redx confirms Jounce deal lapses, Tirupati seals deal	23-04-03	AN
Redx Pharma Shares Fall 5% as Merger With Jounce Therapeutics Fails	23-04-03	MT
Termination of Proposed Business Combination of Jounce Therapeutics, Inc. and Redx Pharma plc	23-04-03	AQ
JOUNCE THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K)	23-03-30	AQ
Jounce Therapeutics, Inc. Expects Resignation of Elizabeth Trehu as Chief Medical Officer	23-03-30	CI
Sector Update: Health Care Stocks Rise in Late Trading	23-03-27	MT
Sector Update: Health Care Stocks Higher in Afternoon Trading	23-03-27	MT
European Stock Markets Close Higher Monday as First Citizens BancShares' Planned Acquisition of Silicon Valley Bank Assets, Deposits Eases Banking Crisis Fears	23-03-27	MT
Piper Sandler Downgrades Jounce Therapeutics to Neutral From Overweight, Adjusts Price Target to $1.85 From $5	23-03-27	MT
Jounce dumps Redx Pharma for acquisition by Concentra; to cut 84% of jobs	23-03-27	RE
Redx Pharma Says Jounce Therapeutics Terminated Merger Deal; Shares Plunge 19%	23-03-27	MT
Jounce Therapeutics Agrees to be Acquired by Concentra Biosciences	23-03-27	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Jounce Therapeutics, Inc.

Equities

JNCE

US4811161011

Summary

Filters